Are we overestimating the penetrance of mutations in SDHB?

Human Mutation

Volumn 31, Issue 6, 2010, Pages 761-762

  Schiavi, Francesca ^a   Milne, Roger L ^b   Anda, Emma ^c   Blay, Pilar ^d   Castellano, Maurizio ^e   Opocher, Giuseppe ^a,f   Robledo, Mercedes ^b,g   Cascón, Alberto ^b,g  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c Universidad Pública de Navarra   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e UNIVERSITY OF BRESCIA   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SUCCINATE DEHYDROGENASE; SDHB PROTEIN, HUMAN;

CANCER RISK; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; GERM LINE; GROUPS BY AGE; HUMAN; LETTER; PARAGANGLIOMA; PEDIGREE; PRIORITY JOURNAL; ADOLESCENT; ADULT; AGED; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; MUTATION; PENETRANCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARAGANGLIOMA; PEDIGREE; PENETRANCE; SUCCINATE DEHYDROGENASE; YOUNG ADULT;

EID: 77952677533     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21269     Document Type: Letter

References (9)

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF. 2003. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117-1130.
2. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O, Henley D, Herman P, Murday V, Niccoli-Sire P, Pasieka JL, Rohmer V, Tucker K, Jeunemaitre X, Marsh DJ, Plouin PF, Robinson BG. 2006. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 91:827-836.
3. Cascon A, Lopez-Jimenez E, Landa I, Leskela S, Leandro-Garcia LJ, Maliszewska A, Leton R, de la Vega L, Garcia-Barcina MJ, Sanabria C, Alvarez-Escola C, Rodriguez-Antona C, Robledo M. 2009a. Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/ paraganglioma. Horm Metab Res 41:672-675.
4. Cascon A, Pita G, Burnichon N, Landa I, Lopez-Jimenez E, Montero-Conde C, Leskela S, Leandro-Garcia LJ, Leton R, Rodriguez-Antona C, Diaz JA, Lopez-Vidriero E, Gonzalez-Neira A, Velasco A, Matias-Guiu X, Gimenez-Roqueplo AP, Robledo M. 2009b. Genetics of pheochromocytoma and paraganglioma in Spanish patients. J Clin Endocrinol Metab 94: 1701-1705.
5. Lange K, Weeks D, Boehnke M. 1988. Programs for pedigree analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol 5:471-472.
6. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C. 2004. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292:943-951.
7. Ricketts C, Woodward ER, Killick P, Morris MR, Astuti D, Latif F, Maher ER. 2008. Germline SDHB mutations and familial renal cell carcinoma. J Natl Cancer Inst 100:1260-1262.
8. Ricketts CJ, Forman JR, Rattenbury E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Ajith Kumar VK, Morrison PJ, Atkinson AB, Douglas F, Ball SG, Cook J, Srirangalingam U, Killick P, Kirby G, Aylwin S, Woodward ER, Evans DG, Hodgson SV, Murday V, Chew SL, Connell JM, Blundell TL, Macdonald F, Maher ER. 2010. Tumour risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 31:41-51.
9. Solis DC, Burnichon N, Timmers HJ, Raygada MJ, Kozupa A, Merino MJ, Makey D, Adams KT, Venisse A, Gimenez-Roqueplo AP, Pacak K. 2009. Penetrance and clinical consequences of a gross SDHB deletion in a large family. Clin Genet 75:354-363.